238 related articles for article (PubMed ID: 11485825)
1. Delayed effects of tamoxifen in hepatocarcinogenesis-resistant Fischer 344 rats as compared with susceptible strains.
Stanley LA; Carthew P; Davies R; Higginson F; Martin E; Styles JA
Cancer Lett; 2001 Sep; 171(1):27-35. PubMed ID: 11485825
[TBL] [Abstract][Full Text] [Related]
2. The role of cell death and cell proliferation in the promotion of rat liver tumours by tamoxifen.
Carthew P; Nolan BM; Edwards RE; Smith LL
Cancer Lett; 1996 Sep; 106(2):163-9. PubMed ID: 8844968
[TBL] [Abstract][Full Text] [Related]
3. Initiating activity of the anti-estrogen tamoxifen, but not toremifene in rat liver.
Williams GM; Iatropoulos MJ; Karlsson S
Carcinogenesis; 1997 Nov; 18(11):2247-53. PubMed ID: 9395228
[TBL] [Abstract][Full Text] [Related]
4. DNA damage as assessed by 32P-postlabelling in three rat strains exposed to dietary tamoxifen: the relationship between cell proliferation and liver tumour formation.
Carthew P; Rich KJ; Martin EA; De Matteis F; Lim CK; Manson MM; Festing MF; White IN; Smith LL
Carcinogenesis; 1995 Jun; 16(6):1299-304. PubMed ID: 7788846
[TBL] [Abstract][Full Text] [Related]
5. Major difference in the hepatocarcinogenicity and DNA adduct forming ability between toremifene and tamoxifen in female Crl:CD(BR) rats.
Hard GC; Iatropoulos MJ; Jordan K; Radi L; Kaltenberg OP; Imondi AR; Williams GM
Cancer Res; 1993 Oct; 53(19):4534-41. PubMed ID: 8402624
[TBL] [Abstract][Full Text] [Related]
6. Cumulative exposure to tamoxifen: DNA adducts and liver cancer in the rat.
Carthew P; Lee PN; Edwards RE; Heydon RT; Nolan BM; Martin EA
Arch Toxicol; 2001 Aug; 75(6):375-80. PubMed ID: 11570696
[TBL] [Abstract][Full Text] [Related]
7. Genotoxic potential of tamoxifen and analogues in female Fischer F344/n rats, DBA/2 and C57BL/6 mice and in human MCL-5 cells.
White IN; de Matteis F; Davies A; Smith LL; Crofton-Sleigh C; Venitt S; Hewer A; Phillips DH
Carcinogenesis; 1992 Dec; 13(12):2197-203. PubMed ID: 1473224
[TBL] [Abstract][Full Text] [Related]
8. Studies of tamoxifen as a promoter of hepatocarcinogenesis in female Fischer F344 rats.
Dragan YP; Fahey S; Street K; Vaughan J; Jordan VC; Pitot HC
Breast Cancer Res Treat; 1994; 31(1):11-25. PubMed ID: 7981451
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the effects of tamoxifen and toremifene on liver and kidney tumor promotion in female rats.
Dragan VP; Vaughan J; Jordan VC; Pitot HC
Carcinogenesis; 1995 Nov; 16(11):2733-41. PubMed ID: 7586193
[TBL] [Abstract][Full Text] [Related]
10. Alterations of drug metabolizing and antioxidant enzyme activities during tamoxifen-induced hepatocarcinogenesis in the rat.
Ahotupa M; Hirsimäki P; Pärssinen R; Mäntylä E
Carcinogenesis; 1994 May; 15(5):863-8. PubMed ID: 8200088
[TBL] [Abstract][Full Text] [Related]
11. Genotoxic effects of the novel mixed antiestrogen FC-1271a in comparison to tamoxifen and toremifene.
Hellmann-Blumberg U; Taras TL; Wurz GT; DeGregorio MW
Breast Cancer Res Treat; 2000 Mar; 60(1):63-70. PubMed ID: 10845810
[TBL] [Abstract][Full Text] [Related]
12. Diethylnitrosamine exposure-responses for DNA ethylation, hepatocellular proliferation, and initiation of carcinogenesis in rat liver display non-linearities and thresholds.
Williams GM; Iatropoulos MJ; Jeffrey AM; Luo FQ; Wang CX; Pittman B
Arch Toxicol; 1999 Sep; 73(7):394-402. PubMed ID: 10550482
[TBL] [Abstract][Full Text] [Related]
13. The effect of tamoxifen and two of its non-isomerizable fixed-ring analogs on multistage rat hepatocarcinogenesis.
Dragan YP; Fahey S; Nuwaysir E; Sattler C; Babcock K; Vaughan J; McCague R; Jordan VC; Pitot HC
Carcinogenesis; 1996 Mar; 17(3):585-94. PubMed ID: 8631149
[TBL] [Abstract][Full Text] [Related]
14. Effects of cigarette smoke and a heterocyclic amine, MeIQx on cytochrome P-450, mutagenic activation of various carcinogens and glucuronidation in rat liver.
Mori Y; Koide A; Kobayashi Y; Furukawa F; Hirose M; Nishikawa A
Mutagenesis; 2003 Jan; 18(1):87-93. PubMed ID: 12473741
[TBL] [Abstract][Full Text] [Related]
15. Toxicology and carcinogenesis studies of riddelliine (CAS No. 23246-96-0) in F344/N rats and B6C3F1 mice (gavage studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 2003 May; (508):1-280. PubMed ID: 12844193
[TBL] [Abstract][Full Text] [Related]
16. Tamoxifen mutagenesis and carcinogenesis in livers of lambda/lacI transgenic rats: selective influence of phenobarbital promotion.
Styles JA; Davies R; Fenwick S; Walker J; White IN; Smith LL
Cancer Lett; 2001 Jan; 162(1):117-22. PubMed ID: 11121869
[TBL] [Abstract][Full Text] [Related]
17. Nonlinearities in 2-acetylaminofluorene exposure responses for genotoxic and epigenetic effects leading to initiation of carcinogenesis in rat liver.
Williams GM; Iatropoulos MJ; Wang CX; Jeffrey AM; Thompson S; Pittman B; Palasch M; Gebhardt R
Toxicol Sci; 1998 Oct; 45(2):152-61. PubMed ID: 9848122
[TBL] [Abstract][Full Text] [Related]
18. Inhibition by dietary hydroquinone of acetylaminofluorene induction of initiation of rat liver carcinogenesis.
Williams GM; Iatropoulos MJ; Jeffrey AM; Duan JD
Food Chem Toxicol; 2007 Sep; 45(9):1620-5. PubMed ID: 17433518
[TBL] [Abstract][Full Text] [Related]
19. Proliferation of carcinogen-damaged hepatocytes during cell-cycle-dependent initiation of hepatocarcinogenesis in the rat.
Kaufmann WK; Rice JM; MacKenzie SA; Smith GJ; Wenk ML; Devor D; Qaqish BF; Kaufman DG
Carcinogenesis; 1991 Sep; 12(9):1587-93. PubMed ID: 1893518
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the effects of tamoxifen and toremifene on rat hepatocarcinogenesis.
Kärki A; Mäntylä E; Hirsimäki Y; Karlsson S; Toikkanen S; Hirsimäki P
Arch Toxicol; 2000 Jul; 74(4-5):249-56. PubMed ID: 10959800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
